{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:11:58Z","timestamp":1791684718309,"version":"4.3.4"},"reference-count":240,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["R.G.P.2\/149\/43"],"award-info":[{"award-number":["R.G.P.2\/149\/43"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Oncology"],"published-print":{"date-parts":[[2022,9,29]]},"abstract":"<jats:p>Cancer has been one of the most dominant causes of mortality globally over the last few decades. In cancer treatment, the selective targeting of tumor cells is indispensable, making it a better replacement for conventional chemotherapies by diminishing their adverse side effects. While designing a drug to be delivered selectively in the target organ, the drug development scientists should focus on various factors such as the type of cancer they are dealing with according to which drug, targeting moieties, and pharmaceutical carriers should be targeted. All published articles have been collected regarding cancer and drug-targeting approaches from well reputed databases including MEDLINE, Embase, Cochrane Library, CENTRAL and ClinicalTrials.gov, Science Direct, PubMed, Scopus, Wiley, and Springer. The articles published between January 2010 and December 2020 were considered. Due to the existence of various mechanisms, it is challenging to choose which one is appropriate for a specific case. Moreover, a combination of more than one approach is often utilized to achieve optimal drug effects. In this review, we have summarized and highlighted central mechanisms of how the targeted drug delivery system works in the specific diseased microenvironment, along with the strategies to make an approach more effective. We have also included some pictorial illustrations to have a precise idea about different types of drug targeting. The core contribution of this work includes providing a cancer drug development scientist with a broad preliminary idea to choose the appropriate approach among the various targeted drug delivery mechanisms. Also, the study will contribute to improving anticancer treatment approaches by providing a pathway for lesser side effects observed in conventional chemotherapeutic techniques.<\/jats:p>","DOI":"10.1155\/2022\/9396760","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T01:35:09Z","timestamp":1664501709000},"page":"1-26","source":"Crossref","is-referenced-by-count":19,"title":["Exploration of Site-Specific Drug Targeting\u2014A Review on EPR-, Stimuli-, Chemical-, and Receptor-Based Approaches as Potential Drug Targeting Methods in Cancer Treatment"],"prefix":"10.1155","volume":"2022","author":[{"given":"Md. Shamiul Islam","family":"Rasel","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana Afrin","family":"Mohona","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahida","family":"Akter","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Houston, Houston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaila","family":"Kabir","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Asad","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakir Ahmed","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abul","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Science & Technology, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9936-3925","authenticated-orcid":true,"given":"Abdullah","family":"Al Mamun","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035 Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipayon Krisna","family":"Ghose","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Jagannath University, Dhaka 1100, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Unit of Bee Research and Honey Production, King Khalid University, Abha 61413, Saudi Arabia"},{"name":"Department of Biology, College of Arts and Sciences, King Khalid University, Abha 61413, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Arts and Sciences, King Khalid University, Abha 61413, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Fazlul","family":"Bari","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Trust University, Barishal, Ruiya, Nobogram Road, Barishal 8200, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1133-268X","authenticated-orcid":true,"given":"Md. Sohanur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Trust University, Barishal, Ruiya, Nobogram Road, Barishal 8200, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6207-1240","authenticated-orcid":true,"given":"Md. Shah","family":"Amran","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Shahbag, Dhaka 1000, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2394"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"issue":"48","key":"3","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1039\/C9TB01842E","article-title":"Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers","volume":"7","author":"F. Raza","year":"2019","journal-title":"Journal of Materials Chemistry B"},{"issue":"6","key":"4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202002081","article-title":"Recent advances in cell membrane-derived biomimetic nanotechnology for cancer immunotherapy","volume":"10","author":"F. Raza","year":"2021","journal-title":"Advanced Healthcare Materials"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1177\/1559325820936161"},{"issue":"5","key":"6","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1039\/D1MA00961C","article-title":"Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy","volume":"3","author":"F. Raza","year":"2021","journal-title":"Advanced Materials"},{"key":"7","article-title":"Chemotherapy causes death in more than 25% of cancer patients - PharmaTimes","author":"K. Megget","year":"2008"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.10.008"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23071704"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-1441"},{"key":"11","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review","volume":"13","author":"N. Muhamad","year":"2018","journal-title":"International Journal of Nanomedicine"},{"issue":"1","key":"12","first-page":"1","article-title":"Targeted drug delivery: a review","volume":"6","author":"N. Mishra","year":"2016","journal-title":"American Journal of PharmTech Research"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060571"},{"issue":"4","key":"14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040670","article-title":"Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting","volume":"13","author":"M. A. Rahim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.9.11.1499"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129777"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.2174\/156800910791190210"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1021\/mp200439z"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.09.012"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1080\/02656730500068643"},{"issue":"8","key":"21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2174\/156800911797264770","article-title":"Active-targeted nanotherapy strategies for prostate cancer","volume":"11","author":"M. Katsogiannou","year":"2011","journal-title":"Cancer Drug Targets"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006536"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2017.05.006"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080771"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1021\/bc100070g"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1080\/10611860701539584"},{"issue":"1","key":"27","first-page":"1","article-title":"Enhanced permeability and retention (EPR) effect based tumor targeting: the concept, application and prospect","volume":"2","author":"H. Yin","year":"2014","journal-title":"JSM Surgical Oncology and Research"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2004.08.004"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.3.213"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1038\/35025220"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21187"},{"issue":"16","key":"33","first-page":"6038","article-title":"Combination of interferon-\u03b2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis","volume":"9","author":"R. Noguchi","year":"2003","journal-title":"Clinical Cancer Research"},{"issue":"16","key":"34","first-page":"4324","article-title":"Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation","volume":"60","author":"A. J. Leu","year":"2000","journal-title":"Cancer Research"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)65006-7"},{"issue":"17","key":"36","article-title":"Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size","volume":"55","author":"F. Yuan","year":"1995","journal-title":"Cancer Research"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1991.tb01797.x"},{"issue":"8","key":"38","article-title":"Microvascular architecture of experimental colon tumors in the rat","volume":"50","author":"S. A. Skinner","year":"1990","journal-title":"Cancer Research"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.158"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-suppl_1-2"},{"issue":"5","key":"41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","article-title":"The role of nitric oxide in cancer","volume":"12","author":"W. Xu","year":"2002","journal-title":"Cell Reserach"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.07.014"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.10.016"},{"issue":"25","key":"44","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2174\/1381612033454171","article-title":"Bradykinin antagonists as anti-cancer agents","volume":"9","author":"J. Stewart","year":"2005","journal-title":"Current Pharmaceutical Design"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01114.x"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0342-8"},{"issue":"11","key":"47","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"X. Wang","year":"2008","journal-title":"Acta Pharmacologica Sinica"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1021\/bc500481x"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1007\/s10047-005-0285-0"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095833"},{"issue":"19","key":"51","first-page":"803","article-title":"Bio-nanotechnology: a revolution in food, biomedical, and health sciences","volume":"18","author":"D. Bagchi","year":"2013","journal-title":"British Journal of Nursing"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)00514-6"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(94)90038-8"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.36770"},{"issue":"18","key":"55","article-title":"Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse","volume":"52","author":"Y. Boucher","year":"1992","journal-title":"Cancer Research"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.148"},{"issue":"22","key":"57","article-title":"Interstitial hypertension in human breast and colorectal tumors","volume":"52","author":"J. R. Less","year":"1992","journal-title":"Cancer Research"},{"issue":"24","key":"58","article-title":"Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response","volume":"51","author":"H. D. Roh","year":"1991","journal-title":"Cancer Research"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2010.05.012"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1172\/jci26532c1"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.179"},{"issue":"3","key":"62","article-title":"Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule","volume":"296","author":"S. H. Jang","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.2745\/dds.18.438"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1991.tb01910.x"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2000.tb00940.x"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1080\/1061186031000086072"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342130-00002"},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.02178.x"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.018"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-05-1222"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00349.x"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1016\/0162-3109(96)00063-x"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1016\/s1567-5769(02)00271-0"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.02.021"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.7150\/thno.13727"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.6b00437"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1038\/339058a0"},{"issue":"23","key":"78","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1073\/pnas.1017945108","article-title":"Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells","volume":"108","author":"W. Chen","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"79","doi-asserted-by":"publisher","DOI":"10.1038\/258731a0"},{"key":"80","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2653"},{"issue":"2","key":"81","first-page":"371","article-title":"The role of isolated limb perfusion for melanoma confined to the extremities","volume":"83","author":"A. M. Eggermont","year":"2003","journal-title":"Surgical Clinics"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.479"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.1.52"},{"key":"84","first-page":"4440","article-title":"Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size","volume":"60","author":"G. Kong","year":"2000","journal-title":"Cancer Research"},{"issue":"16","key":"85","first-page":"4440","article-title":"Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size","volume":"60","author":"K. Garheng","year":"2000","journal-title":"Cancer Research"},{"key":"86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.01.026"},{"key":"87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603366"},{"key":"88","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.119"},{"key":"89","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-0278"},{"key":"90","doi-asserted-by":"publisher","DOI":"10.1593\/neo.06733"},{"key":"91","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-05-2046"},{"issue":"41","key":"92","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1073\/pnas.1117610109","article-title":"TGF-\u03b2 blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma","volume":"109","author":"J. Liu","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"V. P. Chauhan","year":"2013","journal-title":"Nature Communications"},{"issue":"7","key":"94","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"B. Diop-Frimpong","year":"011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.12.018"},{"key":"96","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.121632"},{"key":"97","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-05-1673"},{"key":"98","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.429"},{"issue":"23","key":"99","article-title":"\u201cPhotodynamic therapy","volume":"63","author":"J. W. Snyder","year":"2003","journal-title":"Cancer Reserach"},{"key":"100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2012.04.002"},{"key":"101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.8.4000"},{"key":"102","doi-asserted-by":"publisher","DOI":"10.1021\/nn305011p"},{"issue":"9","key":"103","first-page":"3621","article-title":"Therapeutic efficacy of anti-Lewis (y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy","volume":"6","author":"K. Clarke","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"104","doi-asserted-by":"publisher","DOI":"10.1021\/nn304474j"},{"key":"105","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.09.027"},{"key":"106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.09.011"},{"key":"107","doi-asserted-by":"publisher","DOI":"10.1002\/ange.201814289"},{"key":"108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.08.039"},{"key":"109","doi-asserted-by":"publisher","DOI":"10.1021\/nn506210a"},{"key":"110","doi-asserted-by":"publisher","DOI":"10.1039\/c8bm00243f"},{"key":"111","doi-asserted-by":"publisher","DOI":"10.7150\/thno.12843"},{"key":"112","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.6b00420"},{"key":"113","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.12.019"},{"key":"114","doi-asserted-by":"publisher","DOI":"10.7150\/thno.9199"},{"key":"115","doi-asserted-by":"publisher","DOI":"10.7150\/thno.17251"},{"issue":"1","key":"116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4545","article-title":"Three-layered polyplex micelle as a multifunctional nanocarrier platform for light-induced systemic gene transfer","volume":"5","author":"T. Nomoto","year":"2014","journal-title":"Nature Communications"},{"key":"117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.04.001"},{"key":"118","doi-asserted-by":"publisher","DOI":"10.1039\/c5nr01075f"},{"key":"119","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.07.025"},{"key":"120","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201500061"},{"key":"121","doi-asserted-by":"publisher","DOI":"10.1038\/nmat3776"},{"key":"122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.07.019"},{"key":"123","doi-asserted-by":"publisher","DOI":"10.1021\/nn3018365"},{"issue":"10","key":"124","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1021\/nn302148p","article-title":"Lipid\u2013peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo","volume":"6","author":"Z. S. Al-Ahmady","year":"2012","journal-title":"ACS Nano"},{"key":"125","doi-asserted-by":"publisher","DOI":"10.1007\/s41048-020-00117-8"},{"key":"126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.11.007"},{"key":"127","doi-asserted-by":"publisher","DOI":"10.1021\/bm300823y"},{"key":"128","doi-asserted-by":"publisher","DOI":"10.1021\/nl301529p"},{"key":"129","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2007.07.009"},{"key":"130","doi-asserted-by":"publisher","DOI":"10.1002\/ange.201306557"},{"key":"131","doi-asserted-by":"publisher","DOI":"10.1021\/nn205023w"},{"key":"132","doi-asserted-by":"publisher","DOI":"10.1039\/c2cc31563g"},{"key":"133","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2018.04.013"},{"key":"134","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.01.008"},{"key":"135","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s31564"},{"key":"136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2009.05.026"},{"key":"137","doi-asserted-by":"publisher","DOI":"10.7150\/thno.4306"},{"key":"138","doi-asserted-by":"publisher","DOI":"10.1039\/c8nr00693h"},{"key":"139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.03.025"},{"key":"140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2010.11.004"},{"key":"141","doi-asserted-by":"publisher","DOI":"10.2174\/138920101703160206142821"},{"key":"142","doi-asserted-by":"publisher","DOI":"10.7150\/thno.49784"},{"key":"143","doi-asserted-by":"publisher","DOI":"10.1021\/ma300094t"},{"key":"144","doi-asserted-by":"publisher","DOI":"10.1021\/nn504836s"},{"key":"145","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201503966"},{"key":"146","doi-asserted-by":"publisher","DOI":"10.1021\/nn506516p"},{"key":"147","doi-asserted-by":"publisher","DOI":"10.1021\/ja503115n"},{"key":"148","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b01505"},{"key":"149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.05.025"},{"key":"150","doi-asserted-by":"publisher","DOI":"10.1039\/c6cs00271d"},{"key":"151","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b07521"},{"key":"152","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201103164"},{"key":"153","doi-asserted-by":"publisher","DOI":"10.1002\/adma.200900334"},{"key":"154","doi-asserted-by":"publisher","DOI":"10.1002\/smll.200700903"},{"key":"155","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201203993"},{"key":"156","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.8b07045"},{"key":"157","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.6b08731"},{"key":"158","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.08.014"},{"key":"159","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201901513"},{"key":"160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.08.022"},{"key":"161","doi-asserted-by":"publisher","DOI":"10.7150\/thno.27581"},{"key":"162","doi-asserted-by":"publisher","DOI":"10.1039\/c7py01485f"},{"key":"163","doi-asserted-by":"publisher","DOI":"10.1021\/ja511420n"},{"key":"164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.04.033"},{"key":"165","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b00532"},{"key":"166","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-177"},{"key":"167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.03.050"},{"issue":"1","key":"168","first-page":"1","article-title":"Advances in redox-responsive drug delivery systems of tumor microenvironment","volume":"16","author":"X. Guo","year":"2018","journal-title":"Journal of Nanobiotechnology"},{"key":"169","doi-asserted-by":"publisher","DOI":"10.1021\/ar4000339"},{"key":"170","doi-asserted-by":"publisher","DOI":"10.4155\/tde.13.120"},{"key":"171","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030652"},{"key":"172","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061218"},{"key":"173","doi-asserted-by":"publisher","DOI":"10.1021\/ja908124g"},{"key":"174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.06.011"},{"key":"175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.11.022"},{"key":"176","doi-asserted-by":"publisher","DOI":"10.1021\/bc200139n"},{"key":"177","doi-asserted-by":"publisher","DOI":"10.1038\/nmat2859"},{"key":"178","doi-asserted-by":"publisher","DOI":"10.1021\/nn300524f"},{"key":"179","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.02.045"},{"key":"180","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.08.036"},{"key":"181","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1478"},{"key":"182","doi-asserted-by":"publisher","DOI":"10.7150\/thno.19546"},{"key":"183","doi-asserted-by":"publisher","DOI":"10.7150\/thno.38069"},{"issue":"1","key":"184","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1749-6632.1987.tb45809.x","article-title":"Redox drug delivery systems for targeting drugs to the braina","volume":"507","author":"N. Bodor","year":"1987","journal-title":"Annals of the New York Academy of Sciences"},{"key":"185","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409x(89)90004-5"},{"key":"186","doi-asserted-by":"publisher","DOI":"10.1021\/jm00137a001"},{"key":"187","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.12.005"},{"key":"188","doi-asserted-by":"publisher","DOI":"10.4155\/tde.13.6"},{"key":"189","article-title":"Passive vs. active targeting: an update of the epr role in drug delivery to tumors","author":"J. R. Upponi","year":"2014"},{"issue":"5","key":"190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/CDLI.5.5.645-653.1998","article-title":"Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer","volume":"5","author":"E. M. Rakowicz-Szulczynska","year":"1998","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"6","key":"191","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1476-5586(03)80034-9","article-title":"The transferrin receptor: a potential molecular imaging marker for human cance","volume":"5","author":"D. H\u00f6gemann-Savellano","year":". 2003","journal-title":"Neoplasia"},{"issue":"6","key":"192","first-page":"916","article-title":"Transferrin receptor 1 in cancer: a new sight for cancer therapy","volume":"8","author":"Y. Shen","year":"2018","journal-title":"American Journal of Cancer Research"},{"issue":"1","key":"193","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1039\/C7NR06415B","article-title":"Lectin-gated and glycan functionalized mesoporous silica nanocontainers for targeting cancer cells overexpressing Lewis X antigen","volume":"10","author":"R. Bhat","year":"2017","journal-title":"Nanoscale"},{"key":"194","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","author":"N. Iqbal","year":"2014"},{"issue":"2","key":"195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2011.05.025","article-title":"The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells","volume":"309","author":"X. Bing","year":"2011","journal-title":"Cancer Letters"},{"issue":"1","key":"196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06888-4","article-title":"Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)","volume":"7","author":"S. Kumari","year":"2017","journal-title":"Scientific Reports"},{"key":"197","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0339-5"},{"issue":"1","key":"198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15012-5","article-title":"Chemodrug delivery using integrin-targetedPLGA-Chitosan nanoparticle for lung cancer therapy","volume":"7","author":"A. Babu","year":"2017","journal-title":"Scientific Reports"},{"key":"199","doi-asserted-by":"publisher","DOI":"10.1007\/s10311-020-01022-9"},{"issue":"1","key":"200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06602-6","article-title":"Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the avidin-nucleic-acid-nano-assemblies","volume":"9","author":"F. Roncato","year":"2018","journal-title":"Nature Communications"},{"key":"201","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s161932"},{"key":"202","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4963"},{"key":"203","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00307"},{"key":"204","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2018.06.034"},{"key":"205","doi-asserted-by":"publisher","DOI":"10.1002\/ange.201311227"},{"key":"206","doi-asserted-by":"publisher","DOI":"10.1172\/jci116001"},{"key":"207","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717x-1-11"},{"key":"208","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26436"},{"key":"209","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.6b01688"},{"key":"210","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-08-0244"},{"key":"211","doi-asserted-by":"publisher","DOI":"10.1021\/nn502807n"},{"key":"212","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.10.050"},{"key":"213","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2007.04.004"},{"key":"214","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2006.12.007"},{"key":"215","doi-asserted-by":"publisher","DOI":"10.1080\/10611860600965914"},{"issue":"1","key":"216","first-page":"1","article-title":"Nano based drug delivery systems: recent developments and future prospects 10 technology 1007 nanotechnology 03 chemical sciences 0306 physical chemistry (incl. Structural) 03 chemical sciences 0303 macromolecular and materials chemistry 11 medical and He","volume":"16","author":"J. K. Patra","year":"2018","journal-title":"Journal of Nanobiotechnology"},{"issue":"14","key":"217","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2174\/0929867324666170705143308","article-title":"Applications of cellulose-based materials in sustained drug delivery systems","volume":"26","author":"B. Sun","year":"2018","journal-title":"Current Medicinal Chemistry"},{"issue":"9","key":"218","first-page":"142","article-title":"Dendrimers and their applications as novel drug delivery carriers","volume":"3","author":"S. Tripathy","year":"2013","journal-title":"Journal of Applied Pharmaceutical Science"},{"key":"219","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-1-78242-105-4.00001-8","article-title":"Introduction to biomedical polymers and biocompatibility","author":"L. A. Poole-Warren","year":"2016","journal-title":"Biosynthetic Polymers for Medical Applications"},{"key":"220","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.139"},{"key":"221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.06.001"},{"key":"222","doi-asserted-by":"publisher","DOI":"10.1021\/mp1003652"},{"key":"223","doi-asserted-by":"publisher","DOI":"10.1021\/mp100228v"},{"key":"224","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.10.007"},{"key":"225","doi-asserted-by":"publisher","DOI":"10.4161\/org.6152"},{"issue":"3","key":"226","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"M. E. R. O. \u2019Brien","year":"2004","journal-title":"Annals of Oncology"},{"key":"227","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604561"},{"key":"228","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.10.032"},{"issue":"22","key":"229","article-title":"Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery","volume":"55","author":"P. A. Netti","year":"1995","journal-title":"Cancer Research"},{"issue":"6","key":"230","first-page":"1433","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi\u2019s sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development","volume":"152","author":"F. Samaniego","year":"1998","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"231","first-page":"1","article-title":"Cancer metastasis: issues and challenges","volume":"36","author":"C. N. Qian","year":"2017","journal-title":"Chinese Journal of Cancer"},{"issue":"1\u20132","key":"232","first-page":"1","article-title":"Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data","volume":"91","author":"B \u0158\u00edhov\u00e1","year":"2003","journal-title":"Journal of Controlled Release"},{"key":"233","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2009.10.005"},{"key":"234","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.09.063"},{"issue":"3","key":"235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1549-8719.2010.00029.x","article-title":"Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models","volume":"17","author":"D. Fukumura","year":"2010","journal-title":"Microcirculation"},{"key":"236","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911432334"},{"key":"237","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00389.2001"},{"key":"238","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.15.86"},{"key":"239","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"R. K. Jain","year":"2005","journal-title":"Science"},{"key":"240","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c17-00068"}],"container-title":["Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2022\/9396760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2022\/9396760.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2022\/9396760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T06:58:28Z","timestamp":1666421908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/jo\/2022\/9396760\/"}},"subtitle":[],"editor":[{"given":"Faisal","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":240,"alternative-id":["9396760","9396760"],"URL":"https:\/\/doi.org\/10.1155\/2022\/9396760","relation":{},"ISSN":["1687-8469","1687-8450"],"issn-type":[{"value":"1687-8469","type":"electronic"},{"value":"1687-8450","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}